勃林格应邀参加李强总理同冯德莱恩主席共同出席的中欧企业家座谈会 Boehringer Ingelheim Attends China-EU Business Roundtable with Premier Li Qiang and President von der Leyen
2025年7月24日下午，中国国务院总理李强在北京人民大会堂同欧盟委员会主席冯德莱恩共同出席中欧企业家座谈会。近60位中欧商会和企业负责人出席。勃林格殷格翰大中华区总裁兼首席执行官高皓廷（Mohammed Tawil）先生受邀出席座谈会。
On the afternoon of July 24, 2025, H.E. Li Qiang, Premier of the State Council of the People's Republic of China, and H.E. Ursula von der Leyen, President of the European Commission, jointly attended the China-EU Business Roundtable at the Great Hall of the People in Beijing. Nearly 60 leaders from Chinese and European chambers of commerce and enterprises participated. Mr. Mohammed Tawil, President and CEO of Boehringer Ingelheim Greater China, was invited to attend the roundtable.
图片来源：中央电视台综合频道（CCTV-1）新闻联播
Image source: CCTV-1 Xinwen Lianbo (News Broadcast)
2025年是中欧建交50周年，也是勃林格殷格翰在华发展的第30个年头。在过去30年里，勃林格充分发挥企业优势，在华建立了涵盖研发、生产、商业运营和外部创新合作的全价值链布局。中国是勃林格殷格翰的重点市场和创新高地之一。作为欧洲企业，勃林格殷格翰将持续加大在华研发投入，携手各方伙伴推动开放式创新，实现创新成果加速落地中国，推动中国经验反哺全球，全面改善人与动物的健康，真正做到“在中国，为世界”。
The year 2025 marks the 50th anniversary of diplomatic relations between China and the EU, as well as the 30th year of Boehringer Ingelheim's presence in China. Over the past three decades, Boehringer Ingelheim has leveraged its corporate strengths to establish a full value chain footprint in China encompassing R&D, manufacturing, commercial operations, and external innovation.
China stands as one of Boehringer Ingelheim's focus markets and a source of innovation. As a European enterprise, Boehringer Ingelheim will continue to increase its R&D investment in China, collaborate with partners to foster open innovation, accelerate access of global innovations in China, facilitate the feedback of China's experience to the global community, comprehensively improve the health of both humans and animals, and truly fulfill its commitment of "In China, for the World."
请扫码关注我们
勃林格殷格翰官方
勃林格殷格翰HR
勃林格殷格翰动保